A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(28 sites)

United States

Children's Hospital Los Angeles- Site Number : 8400009, Los Angeles, California

Children's National Medical Center - Washington- Site Number : 8400005, Washington D.C., District of Columbia

Memorial Sloan Kettering Cancer Center - New York - York Avenue- Site Number : 8400001, New York, New York

Texas Children's Hospital- Site Number : 8400008, Houston, Texas

Belgium

Investigational Site Number : 0560003, Ghent

Investigational Site Number : 0560001, Leuven

Canada

Investigational Site Number : 1240002, Toronto, Ontario

China

Investigational Site Number : 1560003, Beijing

Investigational Site Number : 1560001, Shanghai

Investigational Site Number : 1560004, Shenzhen

Investigational Site Number : 1560002, Suzhou

France

Investigational Site Number : 2500002, Marseille

Investigational Site Number : 2500001, Paris

Germany

Investigational Site Number : 2760001, Berlin

Israel

Investigational Site Number : 3760005, Haifa

Investigational Site Number : 3760002, Jerusalem

Investigational Site Number : 3760004, Petah Tikva

Investigational Site Number : 3760003, Ramat Gan

Investigational Site Number : 3760001, Tel Aviv

Italy

Investigational Site Number : 3800002, Milan, Milano

Investigational Site Number : 3800001, Rome, Roma

Netherlands

Investigational Site Number : 5280001, Utrecht

Spain

Investigational Site Number : 7240003, Esplugues de Llobregat, Barcelona [Barcelona]

Investigational Site Number : 7240001, Barcelona

Investigational Site Number : 7240002, Madrid

Turkey (Türkiye)

Investigational Site Number : 7920003, Ankara

United Kingdom

Investigational Site Number : 8260002, Newcastle upon Tyne, England

Investigational Site Number : 8260001, London, London, City of